Detalhe da pesquisa
1.
Broadly Neutralizing Alphavirus Antibodies Bind an Epitope on E2 and Inhibit Entry and Egress.
Cell;
163(5): 1095-1107, 2015 Nov 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26553503
2.
Colocalization of Chikungunya Virus with Its Receptor MXRA8 during Cell Attachment, Internalization, and Membrane Fusion.
J Virol;
97(5): e0155722, 2023 05 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37133449
3.
TLR2 axis on peripheral blood mononuclear cells regulates inflammatory responses to non-infectious immature dengue virus particles.
PLoS Pathog;
18(10): e1010499, 2022 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36240261
4.
Moxidectin and Ivermectin Inhibit SARS-CoV-2 Replication in Vero E6 Cells but Not in Human Primary Bronchial Epithelial Cells.
Antimicrob Agents Chemother;
66(1): e0154321, 2022 01 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34633839
5.
Serotonergic Drugs Inhibit Chikungunya Virus Infection at Different Stages of the Cell Entry Pathway.
J Virol;
94(13)2020 06 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32321803
6.
Dynamics of Chikungunya Virus Cell Entry Unraveled by Single-Virus Tracking in Living Cells.
J Virol;
90(9): 4745-4756, 2016 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26912616
7.
Dengue tropism for macrophages and dendritic cells: the host cell effect.
J Gen Virol;
97(7): 1531-1536, 2016 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27046075
8.
Altered immune response of immature dendritic cells following dengue virus infection in the presence of specific antibodies.
J Gen Virol;
97(7): 1584-1591, 2016 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27121645
9.
Structure of acidic pH dengue virus showing the fusogenic glycoprotein trimers.
J Virol;
89(1): 743-50, 2015 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25355881
10.
Complex interaction between dengue virus replication and expression of miRNA-133a.
BMC Infect Dis;
16: 29, 2016 Jan 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26818704
11.
Molecular mechanisms involved in antibody-dependent enhancement of dengue virus infection in humans.
Traffic;
14(1): 25-35, 2013 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22998156
12.
Chikungunya virus fusion properties elucidated by single-particle and bulk approaches.
J Gen Virol;
96(8): 2122-2132, 2015 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25872739
13.
Development of a highly protective combination monoclonal antibody therapy against Chikungunya virus.
PLoS Pathog;
9(4): e1003312, 2013.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23637602
14.
Viral presence and immunopathology in a kidney transplant recipient with fatal COVID-19: a clinical autopsy report.
J Leukoc Biol;
115(4): 780-789, 2024 Mar 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38252562
15.
Novel high-yield potato protease inhibitor panels block a wide array of proteases involved in viral infection and crucial tissue damage.
J Mol Med (Berl);
102(4): 521-536, 2024 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38381158
16.
Neuroinvasive flavivirus infections.
Rev Med Virol;
22(2): 69-87, 2012 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22086854
17.
Mitochondrial protein BNIP3 regulates Chikungunya virus replication in the early stages of infection.
PLoS Negl Trop Dis;
17(11): e0010751, 2023 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38011286
18.
Characterization of soluble TLR2 and CD14 levels during acute dengue virus infection.
Heliyon;
9(6): e17265, 2023 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37416678
19.
A fusion-loop antibody enhances the infectious properties of immature flavivirus particles.
J Virol;
85(22): 11800-8, 2011 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21880758
20.
Immature dengue virus: a veiled pathogen?
PLoS Pathog;
6(1): e1000718, 2010 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20062797